Literature DB >> 20363041

Dose-rate effects in external beam radiotherapy redux.

C Clifton Ling1, Leo E Gerweck, Marco Zaider, Ellen Yorke.   

Abstract

Recent developments in external beam radiotherapy, both in technical advances and in clinical approaches, have prompted renewed discussions on the potential influence of dose-rate on radio-response in certain treatment scenarios. We consider the multiple factors that influence the dose-rate effect, e.g. radical recombination, the kinetics of sublethal damage repair for tumors and normal tissues, the difference in alpha/beta ratio for early and late reacting tissues, and perform a comprehensive literature review. Based on radiobiological considerations and the linear-quadratic (LQ) model we estimate the influence of overall treatment time on radio-response for specific clinical situations. As the influence of dose-rate applies to both the tumor and normal tissues, in oligo-fractionated treatment using large doses per fraction, the influence of delivery prolongation is likely important, with late reacting normal tissues being generally more sensitive to the dose-rate effect than tumors and early reacting tissues. In conventional fractionated treatment using 1.8-2Gy per fraction and treatment times of 2-1 min, the influence of dose-rate is relatively small. Lastly, the dose-rate effect in external beam radiotherapy is governed by the overall beam-on-time, not by the average linac dose-rate, nor by the instantaneous dose-rate within individual linac pulses which could be as high as 3 x 10(6)MU/min. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20363041     DOI: 10.1016/j.radonc.2010.03.014

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  35 in total

Review 1.  Clinical radioimmunotherapy--the role of radiobiology.

Authors:  Jean-Pierre Pouget; Isabelle Navarro-Teulon; Manuel Bardiès; Nicolas Chouin; Guillaume Cartron; André Pèlegrin; David Azria
Journal:  Nat Rev Clin Oncol       Date:  2011-11-08       Impact factor: 66.675

2.  Impact of flattening-filter-free radiation on the clonogenic survival of astrocytic cell lines.

Authors:  Caroline Steenken; Jens Fleckenstein; Stefan Kegel; Lennart Jahnke; Anna Simeonova; Linda Hartmann; Jens Kübler; Marlon R Veldwijk; Frederik Wenz; Carsten Herskind; Frank Anton Giordano
Journal:  Strahlenther Onkol       Date:  2015-03-13       Impact factor: 3.621

3.  DNA damage enhancement from gold nanoparticles for clinical MV photon beams.

Authors:  Ross I Berbeco; Houari Korideck; Wilfred Ngwa; Rajiv Kumar; Janki Patel; Srinivas Sridhar; Sarah Johnson; Brendan D Price; Alec Kimmelman; G Mike Makrigiorgos
Journal:  Radiat Res       Date:  2012-11-13       Impact factor: 2.841

4.  Effect of varying dose-per-pulse and average dose rate in X-ray beam irradiation on cultured cell survival.

Authors:  G Lasio; M Guerrero; W Goetz; F Lima; J E Baulch
Journal:  Radiat Environ Biophys       Date:  2014-08-29       Impact factor: 1.925

Review 5.  Advances and future of Radiation Oncology.

Authors:  Carlos A Perez; Sasa Mutic
Journal:  Rep Pract Oncol Radiother       Date:  2013-11-08

Review 6.  Preclinical animal research on therapy dosimetry with dual isotopes.

Authors:  Mark W Konijnenberg; Marion de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-01       Impact factor: 9.236

7.  Use of a Linear Accelerator for Conducting In Vitro Radiobiology Experiments.

Authors:  Jing Hao; Anthony Magnelli; Andrew Godley; Jennifer S Yu
Journal:  J Vis Exp       Date:  2019-05-26       Impact factor: 1.355

8.  Dependence of micronuclei assay on the depth of absorbed dose.

Authors:  Seyed Mohammad Mahdi Abtahi; Seyed Mahmoud Reza Aghamiri; Masoumeh Yadolahi; Aziz Mahmoudzadeh
Journal:  Rep Pract Oncol Radiother       Date:  2017-09-17

9.  Dosimetric comparison between volumetric modulated arc therapy planning techniques for prostate cancer in the presence of intrafractional organ deformation.

Authors:  Maria Varnava; Iori Sumida; Michio Oda; Keita Kurosu; Fumiaki Isohashi; Yuji Seo; Keisuke Otani; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2021-03-10       Impact factor: 2.724

10.  Radiobiologically guided optimisation of the prescription dose and fractionation scheme in radiotherapy using BioSuite.

Authors:  J Uzan; A E Nahum
Journal:  Br J Radiol       Date:  2012-03-28       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.